GGHC
SWAV

Gilder Gagnon Howe & Co’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-523,913
Closed -$171M – 287
2024
Q1 		$171M Sell
523,913
-10,080
-2% -$2.47M 2.13% 13
2023
Q4 		$102M Sell
533,993
-15,180
-3% -$2.87M 1.4% 20
2023
Q3 		$109M Sell
549,173
-14,443
-3% -$3.42M 1.66% 14
2023
Q2 		$161M Sell
563,616
-36,342
-6% -$10.1M 2.2% 9
2023
Q1 		$130M Sell
599,958
-105,922
-15% -$20.6M 2.16% 8
2022
Q4 		$145M Sell
705,880
-82,994
-11% -$21M 2.71% 6
2022
Q3 		$219M Sell
788,874
-179,143
-19% -$45.6M 3.83% 3
2022
Q2 		$185M Sell
968,017
-193,142
-17% -$34.1M 3.3% 3
2022
Q1 		$241M Sell
1,161,159
-223,199
-16% -$36.8M 2.23% 7
2021
Q4 		$247M Sell
1,384,358
-82,861
-6% -$16.3M 1.41% 11
2021
Q3 		$302M Sell
1,467,219
-33,834
-2% -$6.64M 1.57% 12
2021
Q2 		$285M Sell
1,501,053
-130,280
-8% -$21.3M 1.4% 13
2021
Q1 		$212M Sell
1,631,333
-230,896
-12% -$27.7M 1.15% 21
2020
Q4 		$193M Sell
1,862,229
-20,500
-1% -$1.78M 0.96% 26
2020
Q3 		$143M Sell
1,882,729
-31,513
-2% -$1.79M 0.88% 27
2020
Q2 		$90.7M Buy
1,914,242
+489,096
+34% +$20.2M 0.71% 45
2020
Q1 		$47.3M Sell
1,425,146
-619,451
-30% -$24.6M 0.57% 65
2019
Q4 		$89.8M Buy
2,044,597
+367,681
+22% +$13.6M 0.93% 36
2019
Q3 		$50.2M Buy
1,676,916
+229,515
+16% +$9.75M 0.58% 58
2019
Q2 		$82.6M Buy
1,447,401
+114,842
+9% +$5.58M 0.83% 45
2019
Q1 		$44.6M Buy
+1,332,559
New +$44.3M 0.48% 63

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Gilder Gagnon Howe & Co's SWAV Position: Q2 2024 in Review

Gilder Gagnon Howe & Co sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 523,913 shares — an estimated $171M sold.

Gilder Gagnon Howe & Co first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $302M in Q3 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Gilder Gagnon Howe & Co reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 523,913 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $171M.
  • Gilder Gagnon Howe & Co first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • Gilder Gagnon Howe & Co's Shockwave Medical, Inc. Common Stock position peaked at $302M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2024, filed 14 Aug 2024.